OncoCyte News

OncoCyte | S-3/A: Registration statement for specified transactions by certain issuers (Amendment)

May 17 17:14 ET

OncoCyte | 8-K: ONCOCYTE REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS

May 15 22:26 ET

OncoCyte | 10-Q: Quarterly report

May 15 16:18 ET

OncoCyte | S-3: Registration statement for specified transactions by certain issuers

May 10 17:34 ET

OncoCyte | DEF 14A: Definitive information statements

Apr 29 17:25 ET

OncoCyte | D: Filing D

Apr 25 13:14 ET

OncoCyte | SC 13G: Statement of acquisition of beneficial ownership by individuals-Bio-Rad Laboratories, Inc(8.99%)

Apr 22 13:31 ET

OncoCyte | 10-K: Annual report

Apr 16 06:09 ET

OncoCyte | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Broadwood Partners, L.P.(37.6%),Broadwood Capital, Inc.(37.6%), etc.

Apr 15 19:30 ET

OncoCyte | 4: Statement of changes in beneficial ownership of securities-10% Owner BROADWOOD PARTNERS, L.P.

Apr 15 19:25 ET

OncoCyte | 4: Statement of changes in beneficial ownership of securities-Director Arno Andrew

Apr 15 06:23 ET

OncoCyte | 4: Statement of changes in beneficial ownership of securities-Officer Riggs Josh

Apr 15 06:19 ET

OncoCyte | 8-K: Current report

Apr 12 06:07 ET

OncoCyte | 8-K: Current report

Apr 11 17:33 ET

OncoCyte | NT 10-K: Others

Apr 1 17:08 ET

OncoCyte | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Pura Vida Investments, LLC(8.45%),Efrem Kamen(8.45%), etc.

Feb 14 17:10 ET

OncoCyte | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-AWM Investment Company, Inc.(9.1%)

Feb 14 15:53 ET

OncoCyte | 8-K: Current report

Jan 23 00:00 ET

OncoCyte: Q3 2023 Earnings Report

Nov 9, 2023 17:19 ET

OncoCyte | 8-K: ONCOCYTE REPORTS THIRD QUARTER 2023 FINANCIAL RESULTS -Launching First Products in 1H 2024- -Conference Call on Thursday, November 9, 2023 at 5:00 a.m. PT / 8:00 a.m. ET-

Nov 9, 2023 07:05 ET